Senseonics Eversense, an implantable CGM | by Olga Pustovalova | Medium
Roche inks deal with Diabeloop to integrate automated insulin delivery | MobiHealthNews
Roche Diagnostics and DexCom Announce Research and Development Agreement | Business Wire
Roche and Diabeloop partner to launch automated insulin delivery solution - HealthTech
Medtronic Diabetes HCP - Resources for providers
Review of the Long-Term Implantable Senseonics Continuous Glucose Monitoring System and Other Continuous Glucose Monitoring Systems - Jeffrey I. Joseph, 2021
Senseonics receives FDA approval for long-lasting Eversense E3 CGM | BioWorld
Solo | Accu-Chek
Accu-Chek® Solo - Tubeless Patch Pump, For Exta Possibilities
Roche introduces MedTech for needle-free control of Diabetes
Senseonics Eversense Continuous Glucose Monitoring System
Sensors | Free Full-Text | Smartphone-Based Electrochemical Systems for Glucose Monitoring in Biofluids: A Review
Roche announces launch of connected blood glucose monitoring system - Med-Tech Innovation
Implantable glucose sensor featuring IDT sensing technology awarded CE Mark - Medical Design and Outsourcing
Continuous Glucose Monitoring Systems Market Forecast - 2031
Diabetesia on X: "Getting an exclusive preview of the new Accu-Chek Insight CGM system. #diabetesmeetup #Roche #EASD2016 https://t.co/N6414AmPFW" / X
Roche joins Senseonics, TypeZero for artificial pancreas trials | MobiHealthNews
Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial - The Lancet
Noninvasive, wearable, and tunable electromagnetic multisensing system for continuous glucose monitoring, mimicking vasculature anatomy | Science Advances
Investor Eavesdropping: Diabetes Tech Updates in Early 2017
Diabetes Technologies — D for diabetes
ADA2018: Senseonics' Implantable CGM Beats Abbott, Dexcom In Head-To-Head Study – But Is Methodology Flawed? :: Pink Sheet
Solutions | Roche Diabetes Care HCP Portal
